Drug Information Association Logo
« Back to Listing

Universal Health Coverage and Health Technology Assessment in Emerging Asia Pacific Countries

Track:
Comparative Effectiveness Research/Global Health Outcomes and Economics

Day & Time:
June 19, 9:00AM - 10:30AM (Pacific Standard Time)

Session Number:
410

Room Number:
7B

Level:
Intermediate

Type:
Session

Title:
Universal Health Coverage and Health Technology Assessment in Emerging Asia Pacific Countries

Chair(s):
Chih-Hwa Wallace Lin, PhD
Researcher and Acting Director, Biotechnology Unit
Board of Science and Technology, Executive Yuan, ROC, Taiwan

Description:
Universal health coverage has been established in Taiwan since 1985. Its effectiveness and efficiency have taken off with health technology assessments since 2007. Various approaches of health coverage in Asia Pacific countries such as Japan, China, and Korea will be discussed.

Learning Objective(s):
Discuss an update on the status of universal health coverage (UHC) in Asia Pacific countries; Discuss an update on the health technology assessment (HTA) for innovative products in Asian Pacific countries; Discuss the future trend for UHC and HTA in emerging Asia Pacific countries.

Presentation(s) & Speaker(s):
Aligning the Scientific Requirements for Asia Pacific HTAs: Applied Learnings from Other Jurisdictions
Lawrence Liberti
Executive Director
Centre For Innovation In Regulatory Science (CIRS), United States

Trends in Emerging Asia Pacific: Health Financing and HTA
Abdulkadir Keskinaslan, MD, MBA, MPH
Head Market Access and External Affairs TR
Novartis Pharma AG, Switzerland

The Universal Coverage and the Experience Sharing from the National Health Authority's Perspective
Mao-Ting Sheen
Director, Taipei Branch office
National Health Insurance Administration, Taiwan, Taiwan